Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance

Amotosalen and ultraviolet A (UVA) photochemical-based pathogen reduction using the Intercept™ Blood System (IBS) is an effective and established technology for platelet and plasma components, which is adopted in more than 40 countries worldwide. Several reports point towards a reduced platelet func...

Descripción completa

Detalles Bibliográficos
Autores principales: Stivala, Simona, Gobbato, Sara, Infanti, Laura, Reiner, Martin F., Bonetti, Nicole, Meyer, Sara C., Camici, Giovanni G., Lüscher, Thomas F., Buser, Andreas, Beer, Jürg H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622849/
https://www.ncbi.nlm.nih.gov/pubmed/28729303
http://dx.doi.org/10.3324/haematol.2017.164137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622849/
https://www.ncbi.nlm.nih.gov/pubmed/28729303
http://dx.doi.org/10.3324/haematol.2017.164137

Ejemplares similares